Boston Scientific BSX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.89B+56.7% | $1.85B+15.9% | $1.59B+128% | $698M-32.9% | ||
| $1.37B+7.8% | $1.27B+6.1% | $1.2B+5.3% | $1.14B+3.9% | ||
| $299M+12.4% | $266M+14.2% | $233M+5.9% | $220M+13.4% | ||
| $269M-23.4% | $351M+47.5% | $238M+8.2% | $220M-24.9% | ||
| —— | —— | $660M+106% | $321M-11.1% | ||
| $296M— | —— | $118M— | —— | ||
| —— | $2M-95.7% | $47M— | —— | ||
| $4.53B+32.0% | $3.44B+37.2% | $2.5B+64.0% | $1.53B-18.4% | ||
| $876M+10.9% | $790M+11.1% | $711M+20.9% | $588M+6.1% | ||
| $1.59B-65.7% | $4.64B+156% | $1.81B— | —— | ||
| -$2.64B+53.6% | -$5.69B-121% | -$2.57B-28.0% | -$2.01B-25.9% | ||
| -$395M-122% | $1.81B— | —— | -$549M— | ||
| $44M— | —— | —— | —— | ||
| —— | -$450M-543% | -$70M— | —— | ||
| $319M+27.6% | $250M-3.5% | $259M-42.4% | $450M+33.1% | ||
| $561M-14.5% | $656M+28.1% | $512M-22.7% | $662M+119% | ||
| $18M+460% | -$5M-109% | $58M— | —— | ||
| -$2M— | —— | —— | —— | ||
| —— | -$79M-33.9% | -$59M— | —— | ||
| —— | —— | -$10M— | —— | ||
| $132M+159% | $51M+750% | $6M-81.3% | $32M-5.9% | ||
| -$84M-265% | -$23M+37.8% | -$37M+47.1% | -$70M+14.6% | ||
| $254M-9.3% | $280M+215% | $89M— | —— | ||
| $258M— | —— | $0— | $0— | ||
| $131M+50.6% | $87M+55.4% | $56M+5.7% | $53M+6.0% | ||
| —— | —— | $0— | —— | ||
| $7M+800% | -$1M+98.7% | -$77M— | —— | ||
| —— | $187M+4,775% | -$4M— | —— | ||
| $282M+22.6% | $230M+26.4% | $182M+33.8% | $136M+23.6% | ||
| $1.6B— | —— | $0— | —— | ||
| $119M+1.7% | $117M— | —— | —— | ||
| $3.66B+38.3% | $2.65B+47.6% | $1.79B+91.0% | $938M-28.7% | ||
| $3.66B+38.3% | $2.65B+47.6% | $1.79B+91.0% | $938M-28.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Boston Scientific generate?
- Boston Scientific (BSX) generated $4.3B in operating cash flow over the trailing twelve months.
- What is Boston Scientific's free cash flow?
- After $866.0M of capital expenditures, Boston Scientific's free cash flow was $3.5B over the trailing twelve months, up 15.3% year over year.
- Where does Boston Scientific's cash flow data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
